Cagent Vascular
1 known investors
Cagent Vascular develops the Serranator, a balloon angioplasty device that uses serration remodeling therapy to gently remodel blood vessels and restore blood flow. The company targets vascular surgeons and interventional radiologists for the treatment of cardiovascular disease.